ALPS Alps Group Inc logo

ALPS Alps Group Inc

Healthcare
$0.71+0.00%OpenMarket Cap: $118.4M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

-0.21

P/S

33.24

EV/EBITDA

-1.76

DCF Value

$-0.02

FCF Yield

-0.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

38.6%

Operating Margin

-1983.1%

Net Margin

-2004.5%

ROE

922.4%

ROA

-3884.2%

ROIC

5301.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$0.00$-828.4K$
Q2 null$0.00$-893.9K$
Q4 null$3.4M$-65.1M$
Q1 null$0.00$-738.6K$

Trading Activity

Insider Trades

View All
Lee Hee Hangdirector
SellMon Apr 20
Poh Chit Laaofficer: See Remarks
SellTue Mar 24
Chua Boon Pingdirector
SellTue Mar 24
Chew Yoke Lingdirector
SellTue Mar 24
Cheing Lye-Pingofficer
SellTue Mar 24

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

MY

Exchange

Beta

-0.08

Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapies. The company aims to create a fair healthcare ecosystem with accessible predictive, preventive, and precision medicine.

Peers